首页 › 滤泡性淋巴瘤 › 密西西比州 › Hattiesburg
Hattiesburg MS 滤泡性淋巴瘤临床试验
3项针对 滤泡性淋巴瘤的研究正在 Hattiesburg及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
招募中3 期
- Hattiesburg Clinic, Hattiesburg
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
招募中3 期
- Hattiesburg Clinic Hematology/Oncology, Hattiesburg
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Hattiesburg
其他城市的 滤泡性淋巴瘤试验
- New York City, NY24 项研究
- Milwaukee, WI19 项研究
- Nashville, TN18 项研究
- Houston, TX18 项研究
- Boston, MA17 项研究
- Baldwin Park, CA16 项研究
- Seattle, WA15 项研究
- Durham, NC15 项研究
- Columbus, OH13 项研究
- Salt Lake City, UT13 项研究
- Chicago, IL12 项研究
- San Antonio, TX12 项研究
Hattiesburg的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。